info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Hookworm diseases

AB1_HOOKWORM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 B76
  • Hospital discharge: ICD-9 126
  • Hospital discharge: ICD-8 126
  • Cause of death: ICD-10 B76
  • Cause of death: ICD-9 126
  • Cause of death: ICD-8 126

2 out of 7 registries used, show all original rules.

29

4. Check minimum number of events

None

29

5. Include endpoints

None

29

6. Filter based on genotype QC (FinnGen only)

29

Control definitions (FinnGen only)

Control exclude
AB1_HELMINTIASES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 327 164 158
Only index persons 295 153 142
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 31.76 29.59 34.02
Only index persons 31.31 29.47 33.29

-FinnGen-

Key figures

All Female Male
Number of individuals 29 18 11
Unadjusted period prevalence (%) 0.01 0.01 0.00
Median age at first event (years) 32.62 31.11 35.08

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
15
81
2.76
1.85
2.2
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
24
2.88
1.38
1.3
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
19
2.96
1.27
1.0
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
0
29
0.00
1.04
0.0
1.7
—
24.5
—
0
22
(21494755) Public health laboratory ask at order entry panel
0
30
0.00
1.04
0.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
53
2.01
0.87
1.1
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
26
0.00
0.83
0.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
38
2.10
0.81
1.9
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
23
2.41
0.80
1.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
27
2.02
0.72
2.8
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
10
65
1.82
0.66
1.2
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
22
187
1.73
0.52
3.4
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
49
1.56
0.50
2.1
2.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
9
64
1.59
0.45
1.0
2.2
u/l
269.2
150.3
—
9
64
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
33
1.62
0.44
3.0
2.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
5
76
0.59
0.43
4.6
4.4
mmol/l
2.3
2.4
—
5
68
(3024731) MCV [Entitic volume]
29
275
+∞
0.42
14.1
18.0
fl
90.7
90.4
0.15
29
270
(3035941) MCH [Entitic mass]
29
275
+∞
0.42
14.0
18.0
pg
30.5
30.3
0.26
29
270
(3000963) Hemoglobin [Mass/volume] in Blood
29
275
+∞
0.42
14.2
18.1
g/l
137.7
137.3
0.05
29
270
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.42
0.0
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
0
15
0.00
0.42
0.0
2.5
—
330.4
—
0
15
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
16
0.00
0.42
0.0
2.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
11
138
0.67
0.37
3.5
4.1
mmol/l
7.4
6.4
0.46
11
125
(3023103) Potassium [Moles/volume] in Serum or Plasma
22
236
0.72
0.34
9.8
14.0
mmol/l
3.9
3.9
0.03
22
229
(3018095) Leukocytes [#/volume] in Urine
12
95
1.45
0.33
2.8
3.4
e6/l
5.3
55.1
—
7
70
(3019550) Sodium [Moles/volume] in Serum or Plasma
22
235
0.74
0.33
9.5
13.9
mmol/l
138.9
139.7
0.47
22
229
(1761868) Lipid panel - Serum or Plasma
12
96
1.43
0.31
2.0
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
8
65
1.32
0.31
3.4
6.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
71
1.39
0.30
2.4
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
9
73
1.34
0.30
1.9
2.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
23
207
1.54
0.29
12.7
16.5
%
13.4
13.8
0.77
23
202
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
19
169
1.36
0.24
8.0
3.9
pmol/l
15.7
14.7
1.07
19
152
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.22
0.0
3.5
—
169.2
—
0
10
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
10
0.00
0.22
0.0
2.4
—
92.7
—
0
10
(3016879) Cocaine [Presence] in Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
6
50
1.25
0.21
2.3
2.2
mosm/kgh2o
608.7
589.0
—
6
44
(40760892) CBC W Ordered Manual Differential panel - Blood
6
50
1.25
0.21
2.7
7.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
18
162
1.29
0.18
3.8
4.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
75
0.75
0.18
4.0
2.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
23
215
1.34
0.18
9.0
15.9
g/l
333.7
333.4
0.04
23
215
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
94
1.27
0.16
2.5
2.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
22
224
0.93
0.09
3.9
3.9
mmol/l
6.0
5.7
0.47
22
204
(3026008) Bacteria identified in Urine by Culture
6
73
0.78
0.09
4.0
2.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
18
172
1.12
0.03
2.9
4.4
mm/h
8.9
9.6
0.13
18
162
(3044889) 12 lead EKG panel
14
148
0.90
0.03
2.5
3.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
58
1.04
0.00
3.7
3.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
7
75
0.91
0.00
2.6
6.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
3.4
—
11.6
—
0
5
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
42.2
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
554.4
—
0
5
(3015736) pH of Urine
9
91
0.98
0.00
4.9
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
5
51
0.98
0.00
5.2
2.7
—
1.0
—
0
8
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
23
226
1.09
0.00
9.7
11.0
ml/min/173m2
86.5
86.7
0.01
15
183
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
6
0.00
0.00
0.0
3.3
—
70.5
—
0
6
(4268621)
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
10
100
1.00
0.00
4.3
4.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
6
61
0.98
0.00
2.3
3.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
0
6
0.00
0.00
0.0
8.2
—
34.2
—
0
6
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
97
0.90
0.00
4.7
3.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
54
0.91
0.00
1.2
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
7
70
1.00
0.00
2.3
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
5
52
0.95
0.00
2.2
3.2
ng/l
369.0
1183.2
—
5
42
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.3
—
129.6
—
0
7
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
7
0.00
0.00
0.0
1.0
—
1.0
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
95.4
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
95.3
—
0
5
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
91.9
—
0
6
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
5
58
0.83
0.00
2.6
2.1
e6/l
1.1
5.0
—
5
52
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
5.0
—
0
6
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
8
0.00
-0.00
0.0
3.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_HOOKWORM and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_HOOKWORM.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: AB1_HOOKWORM – Hookworm diseases

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data